Transcriptional provirus silencing as a crosstalk of de novo DNA methylation and epigenomic features at the integration site

Nucleic Acids Research

Volumn 40, Issue 12, 2012, Pages 5298-5312

  Šenigl, Filip ^a   Auxt, Miroslav ^a   Hejnar, Jiří ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; HISTONE H3; LYSINE; METHYL CPG BINDING PROTEIN; VIRUS VECTOR;

ARTICLE; CPG ISLAND; DNA METHYLATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; EPIGENETICS; GENE FUNCTION; GENE SILENCING; GENETIC ASSOCIATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; LEUKEMIA VIRUS; LONG TERMINAL REPEAT; MOLECULAR CLONING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMA VIRUS; STABLE EXPRESSION; TRANSCRIPTION INITIATION SITE; VIRUS DNA CELL DNA INTERACTION;

ALPHARETROVIRUS; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; GENE SILENCING; HUMANS; PROVIRUSES; TRANSCRIPTION, GENETIC; VIRUS INTEGRATION;

AVES;

EID: 84863214203     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks197     Document Type: Article

References (77)

1. Jordan,A., Defechereux,P. and Verdin,E. (2001) The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J., 20, 1726-1738. (Pubitemid 32299409)
2. Jordan,A., Bisgrove,D. and Verdin,E. (2003) HIV reproducibly establishes a latent infection after acute infection of T cells. EMBO J., 22, 1868-1877. (Pubitemid 36460143)
3. Elleder,D., Pavlicek,A., Paces,J. and Hejnar,J. (2001) Preferential integration of human immunodeficiency virus type 1 into genes, cytogenetic R bands and GC-rich regions: insight from the human genome sequence. FEBS Lett., 517, 285-286. (Pubitemid 34327676)
4. Schroder,A.R., Shinn,P., Chen,H., Berry,C., Ecker,J.R. and Bushman,F. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell, 110, 521-529. (Pubitemid 35232295)
5. Mitchell,R.S., Beitzel,B.F., Schroder,A.R., Shinn,P., Chen,H., Berry,C.C., Ecker,J.R. and Bushman,F.D. (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol., 2, e234.
6. Ciuffi,A., Llano,M., Poeschla,E., Hoffmann,C., Leipzig,J., Shinn,P., Ecker,J.R. and Bushman,F. (2005) A role of LEDGF/p75 in targeting HIV DNA integration. Nat. Med., 11, 1287-1289. (Pubitemid 41752906)
7. Shun,M.C., Raghavendra,N.K., Vandegraaff,N., Daigle,J.E., Hughes,S., Kellam,P., Cherepanov,P. and Engelman,A. (2007) LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev., 21, 1767-1778. (Pubitemid 47076476)
8. Meehan,A.M., Saenz,D.T., Morrison,J.H., Garcia-Rivera,J.A., Peretz,M., Llano,M. and Poeschla,E.M. (2009) LEDGF/p75 proteins with alternative chromatin tethers are functional HIV-1 cofactors. PLoS Pathog., 5, e1000522.
9. Wu,X., Li,Y., Crise,B. and Burgess,S.M. (2003) Transcription start regions in the human genome are favored targets for \MLV integration. Science, 300, 1749-1751. (Pubitemid 36712571)
10. Trobridge,G.D., Miller,D.G., Jacobs,M.A., Allen,J.M., Kiem,H.P., Kaul,R. and Russell,D.W. (2006) Foamy virus vector integration sites in normal human cells Proc. Natl Acad. Sci. USA, 103, 1498-1503. (Pubitemid 43191194)
11. Hacein-Bey-Abina,S., Garrigue,A., Wang,G.P., Soulier,J., Lim,A., Morillon,E., Clappier,E., Caccavelli,L., Delabesse,E., Beldjord,K. et al. (2008) Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest., 118, 3132-3142.
12. Studamire,B. and Goff,S.P. (2008) Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors. Retrovirology, 5, e48.
13. Narezkina,A., Taganov,K.D., Litwin,S., Stoyanova,R., Hayashi,J., Seeger,C., Skalka,A.M. and Katz,R.A. (2004) Genome-wide analyses of avian sarcoma virus integration sites. J. Virol., 78, 11656-11663. (Pubitemid 39390752)
14. Barr,S.D., Leipzig,J., Shinn,P., Ecker,J.R. and Bushman,F.D. (2005) Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome. J. Virol., 79, 12035-12044. (Pubitemid 41279320)
15. Faschinger,A., Rouault,F., Sollner,J., Lukas,A., Salmons,B., Günzburg,W.H. and Indik,S. (2008) Mouse mammary tumor virus integration site selection in human and mouse genomes. J. Virol., 82, 1360-1367.
16. Lewinski,M.K., Bisgrove,D., Shinn,P., Chen,H., Hoffmann,C., Hannenhalli,S., Verdin,E., Berry,C.C., Ecker,J.R. and Bushman,F.D. (2005) Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J. Virol., 79, 6610-6619. (Pubitemid 40677292)
17. Shan,L., Yang,H.-C., Rabi,A., Bravo,H.C., Shroff,N.S., Irizarry,R.A., Zhang,H., Margolick,J.B., Siliciano,J.D. and Siliciano,R.F. (2011) Influence of host cell transcriptional level and orientation on HIV-1 latency in a primary-cell model. J. Virol., 85, 5384-5393.
18. Plachy,J., Kotab,J., Divina,P., Reinisova,M., Senigl,F. and Hejnar,J. (2010) Proviruses selected for high and stable expression of transduced genes accumulate in broadly transcribed genome areas. J. Virol., 84, 4204-4211.
19. Wolf,D. and Goff,S.P. (2007) TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell, 131, 46-57. (Pubitemid 47498526)
20. Wolf,D. and Goff,S.P. (2009) Embryonic stem cells use ZFP809 to silence retroviral DNAs. Nature, 458, 1201-1204.
21. Rowe,H.M., Jakobsson,J., Mesnard,D., Rougemont,J., Reynard,S., Aktas,T., Maillard,P.V., Layard-Lieschinget,H., Verp,S., Marquis,J. et al. (2010) KAP1 controls endogenous retroviruses in embryonic stem cells. Nature, 463, 237-240.
22. Niwa,O., Yokota,Y., Ishida,H. and Sugahara,T. (1983) Independent mechanisms involved in suppression of the Moloney leukemia virus genome during differentiation of murine teratocarcinoma cells. Cell, 32, 1105-1113. (Pubitemid 13033049)
23. Petersen,R., Kempler,G. and Barklis,E. (1991) A stem cell-specific silencer in the primer-binding site of a retrovirus. Mol. Cell. Biol., 11, 1214-1221. (Pubitemid 21895477)
24. Grez,M., Akgün,E., Hilberg,F. and Ostertag,W. (1990) Embryonic stem cell virus, a rekombinant murine retrovirus with expression in embryonic stem cells. Proc. Natl Acad. Sci. USA, 87, 9202-9206. (Pubitemid 120030593)
25. Challita,P.M., Skelton,D., el-Khoueiry,A., Yu,X.J., Weinberg,K. and Kohn,D.B. (1995) Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J. Virol., 69, 748-755.
26. Stewart,C.L., Stuhlmann,H., Jähner,D. and Jaenisch,R. (1982) De novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells. Proc. Natl Acad. Sci. USA, 79, 4098-4102. (Pubitemid 12035085)
27. Lorincz,M.C., Schübeler,D., Goeke,S.C., Walters,M., Groudine,M. and Martin,D.I. (2000) Dynamic analysis of proviral induction and de novo methylation: implications for a histone deacetalase-independent, methylation density-dependent mechanism of transcriptional repression. Mol. Cell. Biol., 20, 842-850. (Pubitemid 30044221)
28. Lorincz,M.C., Schübeler,D. and Groudine,M. (2001) Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation. Mol. Cell. Biol., 21, 7913-7922. (Pubitemid 33051784)
29. Lorincz,M.C., Schübeler,D., Hutchinson,S.R., Dickerson,D.R. and Groudine,M. (2002) DNA methylation density influences the stability of an epigenetic imprint and Dnmt3a/b-independent de novo methylation. Mol. Cell. Biol., 22, 7572-7580.
30. Hejnar,J., Plachy,J., Geryk,J., Machon,O., Trejbalova,K., Guntaka,R.V. and Svoboda,J. (1999) Inhibition of the Rous sarcoma virus long terminal repeat-driven transcription by in vitro methylation: different sensitivity in permissive chicken cells versus mammalian cells. Virology, 255, 171-181. (Pubitemid 29391705)
31. Bednarik,D.P., Cook,J.A. and Pitha,P.M. (1990) Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency. EMBO J., 9, 1157-1164. (Pubitemid 120012374)
32. Blazkova,J., Trejbalova,K., Gondois-Rey,F., Halfon,P., Philibert,P., Guiguen,A., Verdin,E., Olive,D., Van Lint,C. and Hejnar,J. (2009) CpG methylation controls reactivation of HIV from latency. PLoS Pathog., 5, e1000554.
33. Kauder,S.E., Bosque,A., Lindqvist,A., Planelles,V. and Verdin,E. (1999) Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog., 5, 1000495.
34. Koiwa,T., Hamano-Usami,A., Ishida,T., Okayama,A., Yamaguchi,K., Kamihira,S. and Watanabe,T. (2002) 5′-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J. Virol., 76, 9389-9397. (Pubitemid 34919896)
35. Taniguchi,Y., Nosaka,K., Yasunaga,J., Maeda,M., Mueller,N., Okayama,A. and Matsuoka,M. (2005) Silencing of human T-cell leukemia virus type 1 gene transcription by epigenetic mechanisms. Retrovirology, 2, e64.
36. Lavie,L., Kitova,M., Maldener,E., Meese,E. and Mayer,J. (2005) CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K (HML-2). J. Virol., 79, 876-883. (Pubitemid 40053871)
37. Matouskova,M., Blazkova,J., Pajer,P., Pavlicek,A. and Hejnar,J. (2006) CpG methylation suppresses transcriptional activity of human syncytin-1 in non-placental tissues. Exp. Cell. Res., 312, 1011-1020.
38. Gimenez,J., Montgiraud,C., Oriol,G., Pichon,J.P., Ruel,K., Tsatsaris,V., Gerbaud,P., Frendo,J.L., Evain-Brion,D. and Mallet,F. (2009) Comparative methylation of ERVWE1/syncytin-1 and other human endogenous retrovirus LTRs in placenta tissues. DNA Res., 16, 195-211.
39. Trejbalova,K., Blazkova,J., Matouskova,M., Kucerova,D., Pecnova,L., Vernerova,Z., Heracek,J., Hirsch,I. and Hejnar,J. (2011) Epigenetic regulation of transcription and splicing of syncytins, fusogenic glycoproteins of retroviral origin. Nucleic Acids Res., 39, 8728-8739.
40. Swindle,C.S., Kim,H.G. and Klug,C.A. (2004) Mutation of CpGs in the murine stem cell virus retroviral vector long terminal repeat represses silencing in embryonic stem cells. J. Biol. Chem., 279, 34-41. (Pubitemid 38044796)
41. Hejnar,J., Hajkova,P., Plachy,J., Elleder,D., Stepanets,V. and Svoboda,J. (2001) CpG island protects Rous sarcoma virus-derived vectors integrated into nonpermissive cells from DNA methylation and transcriptional suppression. Proc. Natl Acad. Sci. USA, 98, 565-569. (Pubitemid 32105082)
42. Senigl,F., Plachy,J. and Hejnar,J. (2008) The core element of a CpG island protects avian sarcoma and leukosis virus-derived vectors from transcriptional silencing. J. Virol., 72, 7818-7827.
43. Pannell,D., Osborne,C.S., Yao,S., Sukonnik,T., Pasceri,P., Karaiskakis,A., Okano,M., Li,E., Lipshitz,H.D. and Ellis,J. (2000) Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code. EMBO J., 19, 5884-5894.
44. Yao,S., Sukonnik,T., Kean,T., Bharadwaj,R.R., Pasceri,P. and Ellis,J. (2004) Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications. Mol. Therapy, 10, 27-36. (Pubitemid 38878146)
45. Mikkelsen,T.S., Kum,M., Jaffe,D.B., Issac,B., Lieberman,E., Giannoukos,G., Alvarez,P., Brockman,W., Kim,T.K., Koche,R.P. et al. (2007) Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature, 448, 553-560. (Pubitemid 47206934)
46. Dong,K.B., Maksakova,I.A., Mohn,F., Leung,D., Appanah,R., Lee,S., Yang,H.W., Lam,L.L., Mager,D.L., Schübeler,D. et al. (2008) DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activity. EMBO J., 27, 2691-2701.
47. Matsui,T., Leung,D., Miyashita,H., Maksakova,I.A., Miyachi,H., Kimura,H., Tachibana,M., Lorincz,C.M. and Shinkai,Y. (2010) Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature, 464, 927-931.
48. Leung,D.C., Dong,K.B., Maksakova,I.A., Goyal,P., Appanah,R., Lee,S., Tachibana,M., Shinkai,Y., Lehnertz,B., Mager,D.L. et al. (2011) Lysine methyltransferase G9a is required for de novo DNA methylation and the establishment, but not the maintenance, of proviral silencing. Proc. Natl Acad. Sci. USA, 108, 5718-5723.
49. Poleshko,A., Einarson,M.B., Shalginskich,N., Zhang,R., Adams,P., Skalka,A.M. and Katz,R.A. (2010) Identification of a functional network of human epigenetic silencing factors. J. Biol. Chem., 285, 422-433.
50. Federspiel,M.J. and Hughes,S.H. (1997) Retroviral gene delivery. Methods Cell. Biol., 52, 179-214. (Pubitemid 128787394)
51. Rhee,I., Jair,K.W., Yen,R.W., Lengauer,C., Herman,J.G., Kinzler,K.W., Vogelstein,B., Baylin,S.B. and Schuebel,K.E. (2000) CpG methylation is maintained in human cancer cells lacking DNMT1. Nature, 404, 1003-1007. (Pubitemid 30243595)
52. Rhee,I., Bachman,K.E., Park,B.H., Jair,K.W., Yen,R.W., Schuebel,K.E., Cui,H., Feinberg,A.P., Lengauer,C., Kinzler,K.W. et al. (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature, 416, 552-556. (Pubitemid 34288859)
53. Jair,K.W., Bachman,K.E., Suzuki,H., Ting,A.H., Rhee,I., Yen,R.W., Baylin,S.B. and Schuebel,K.E. (2006) De novo CpG island methylation in human cancer cells. Cancer Res., 66, 682-692. (Pubitemid 43165930)
54. Uren,A.G., Mikkers,H., Kool,J., van der Weyden,L., Lund,A.H., Wilson,C.H., Rance,R., Jonkers,J., van Lohuizen,M., Berns,A. et al. (2009) A high-throughput splinkerette-PCR method for the isolation and sequencing of retroviral insertion sites. Nat. Protoc., 4, 789-798.
55. Shen,L., Gao,G., Zhang,Y., Zhang,H., Ye,Z., Huang,S., Huang,J. and Kang,J. (2010) A single amino acid substitution confers enhanced methylation activity of mammalian Dnmt3b on chromatin DNA. Nucleic Acids Res., 38, 6054-6064.
56. Holz-Schietinger,C. and Reich,N.O. (2010) The inherent processivity of the human DNA methyltransferase 3 a (DNMT3A) is enhanced by DNMT3L. J. Biol. Chem., 285, 29091-29100.
57. Okitsu,C.Y., Hsieh,J.C. and Hsieh,C.L. (2010) Transcriptional activity affects the H3K4me3 level and distribution in the coding region. Mol. Cell. Biol., 30, 2933-2936.
58. Zhou,V.W., Goren,A. and Bernstein,B.E. (2011) Charting histone modifications and the functional organization of mammalian genomes Nat. Rev. Genet., 12, 7-18.
59. Ooi,S.K., Qiu,C., Bernstein,E., Li,K., Jia,D., Yang,Z., Erdjument-Bromage,H., Tempst,P., Lin,S.P., Allis,C.D. et al. (2007) DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature, 448, 714-717. (Pubitemid 47236857)
60. Wu,H., Coskun,V., Tao,J., Xie,W., Ge,W., Yoshikawa,K., Li,E., Zhang,Y. and Sun,Y.E. (2010) Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neuronic genes. Science, 329, 444-448.
61. Dhayalan,H., Rajavelu,A., Rathert,P., Tamas,R., Jurkowska,R.Z., Ragozin,S. and Jeltsch,A. (2010) The Dnmt3a PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation. J. Biol. Chem., 285, 26114-26120.
62. Macleod,D., Charlton,J., Mullins,J. and Bird,A.P. (1994) Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev., 8, 2282-2292. (Pubitemid 24314290)
63. Weber,M., Hellmann,I., Stadler,M.B., Ramos,L., Paabo,S., Rebhan,M. and Schübeler,D. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet., 39, 457-466. (Pubitemid 46514772)
64. Hodges,E., Smith,A.D., Kendall,J., Xuan,Z., Ravi,K., Rooks,M., Zhang,M.Q., Ye,K., Bhattacharjee,A., Brizuela,L. et al. (2009) High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing. Genome Res., 19, 1593-1605.
65. Jacinto,F.V., Ballestar,E. and Esteller,M. (2009) Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation. Oncogene, 28, 4212-4224.
66. Yang,P.K. and Kuroda,M.I. (2007) Noncoding RNAs and intracellular positioning in monoallelic gene expression. Cell, 128, 777-786. (Pubitemid 46273575)
67. Carrozza,M.J., Li,B., Florens,L., Suganuma,T., Swanson,S.K., Lee,K.K., Shia,W.J., Anderson,S., Yates,J., Washburn,M.P. et al. (2005) Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell, 123, 581-592. (Pubitemid 41608462)
68. Yoh,S.M., Lucas,J.S. and Jones,K.A. (2008) The Iws1:Spt6:CTD complex controls cotranscriptional mRNA biosynthesis and HYPB/Setd2-mediated histone H3K36 methylation. Genes Dev., 22, 3422-3434.
69. Lickwar,C.R., Rao,B., Shabalin,A.A., Nobel,A.B., Strahl,B.D. and Lieb,J.D. (2009) The Set2/Rpd3S pathway suppresses cryptic transcription without regard to gene length or transcription frequency. PloS One, 4, e4886.
70. Searle,S., Gillespie,D.A.F., Chiswell,D.J. and Wyke,J.A. (1984) Analysis of the variations in proviral cytosine methylation that accompany transformation and morphological reversion in a line of Rous sarcoma virus-infected Rat-1 cells. Nucleic Acids Res., 12, 5193-5210.
71. Hejnar,J., Svoboda,J., Geryk,J., Fincham,V.J. and Hak,R. (1994) High rate of morphological reversion in tumor cell line H-19 associated with permanent transcriptional suppression of the LTR, v-src, LTR provirus. Cell Growth Differ., 5, 277-285. (Pubitemid 24251377)
72. Poleshko,A., Palagin,I., Zhang,R., Boimel,P., Castagna,C., Adams,P.D., Skalka,A.M. and Katz,R.A. (2008) Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral response. J. Virol., 82, 2313-2323. (Pubitemid 351293531)
73. He,J., Yang,Q. and Chang,L.-J. (2005) Dynamic DNA methylation and histone modifications contribute to lentiviral transgene silencing in murine embryonic carcinoma cells. J. Virol., 79, 13497-13508. (Pubitemid 41508162)
74. Ellis,J. (2005) Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum. Gene Therapy, 16, 1241-1246.
75. Trono,D., Van Lint,C., Rouzioux,C., Verdin,E., Barré-Sinoussi,F., Chun,T.W. and Chomont,N. (2010) HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals. Science, 329, 174-180.
76. Keedy,K.S. and Margolis,D.M. (2010) Therapy for persistent HIV. Trends Pharmacol. Sci., 31, 206-211.
77. Mok,H.P., Javed,S. and Lever,A. (2007) Stable gene expression occurs from a minority of integrated HIV-1-based vectors: transcriptional silencing is present in the majority. Gene Therapy, 14, 741-751. (Pubitemid 46585655)